FDA Approved: TOBI — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for TOBI (tobramycin inhalation solution) from Viatris Specialty LLC, approving changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• TOBI (Tobramycin inhalation solution)

Snippet

SUPPL AP for TOBI (TOBRAMYCIN)